{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T07:55:20Z","timestamp":1790063720374,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1106556"],"award-info":[{"award-number":["1106556"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["12620000520932"],"award-info":[{"award-number":["12620000520932"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Western Pacific"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.lanwpc.2024.101144","type":"journal-article","created":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T07:20:45Z","timestamp":1720855245000},"page":"101144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Ivermectin therapy for young children with scabies infection: a\u00a0multicentre phase 2 non-randomized trial"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4016-8986","authenticated-orcid":false,"given":"Amanda","family":"Gwee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Steer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khampheng","family":"Phongluxa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanthaly","family":"Luangphaxay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khanpaseuth","family":"Senggnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammala","family":"Philavanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett","family":"McWhinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus","family":"Ungerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Duffull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3295-619X","authenticated-orcid":false,"given":"Xiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Coghlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanwpc.2024.101144_bib1","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1473-3099(21)00557-0","article-title":"Mass drug administration of ivermectin and dihydroartemisinin-piperaquine against malaria in settings with high coverage of standard control interventions: a cluster-randomised controlled trial in the Gambia","volume":"22","author":"Dabira","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2024.101144_bib2","series-title":"WHO informal consultation on a framework for scabies control","first-page":"19","year":"2019"},{"key":"10.1016\/j.lanwpc.2024.101144_bib3","series-title":"Ending the neglect to attain the sustainable development goals: a strategic framework for integrated control and management of skin-related neglected tropical diseases","year":"2022"},{"key":"10.1016\/j.lanwpc.2024.101144_bib4","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S1473-3099(17)30483-8","article-title":"The global burden of scabies: a cross-sectional analysis from the global burden of disease study 2015","volume":"17","author":"Karimkhani","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2024.101144_bib5","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJM199004193221604","article-title":"A\u00a0controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis","volume":"322","author":"Ottesen","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanwpc.2024.101144_bib6","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S1473-3099(17)30636-9","article-title":"Scabies and mortality","volume":"17","author":"Lynar","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2024.101144_bib9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1046\/j.1525-1470.1999.00124.x","article-title":"Before using ivermectin therapy for scabies","volume":"16","author":"Burkhart","year":"1999","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.lanwpc.2024.101144_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/cpt.1456","article-title":"Ivermectin dosing strategy to achieve equivalent exposure coverage in children and adults","volume":"106","author":"Brussee","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lanwpc.2024.101144_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009144","article-title":"A\u00a0systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: is it time to reconsider the current contraindication?","volume":"15","author":"Jittamala","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101144_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008886","article-title":"Population pharmacokinetics of ivermectin for the treatment of scabies in Indigenous Australian children","volume":"14","author":"Gwee","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101144_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12895-018-0079-8","article-title":"Assessing skin disease and associated health-related quality of life in a rural Lao community","volume":"18","author":"Wootton","year":"2018","journal-title":"BMC Dermatol"},{"key":"10.1016\/j.lanwpc.2024.101144_bib14","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/bjd.18943","article-title":"The 2020 international alliance for the control of scabies consensus criteria for the diagnosis of scabies","volume":"183","author":"Engelman","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lanwpc.2024.101144_bib15","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/archdischild-2013-303720","article-title":"Understanding dosing: children are small adults, neonates are immature children","volume":"98","author":"Anderson","year":"2013","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.lanwpc.2024.101144_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A\u00a0method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.lanwpc.2024.101144_bib17","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5414\/CPP39350","article-title":"Limits of 80%-125% for AUC and 70%-143% for Cmax. What is the impact on bioequivalence studies?","volume":"39","author":"Hauck","year":"2001","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.lanwpc.2024.101144_bib18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpba.2019.04.007","article-title":"Development and validation of an LC-MS\/MS method for the analysis of ivermectin in plasma, whole blood, and dried blood spots using a fully automatic extraction system","volume":"172","author":"Duthaler","year":"2019","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.lanwpc.2024.101144_bib19","first-page":"35","article-title":"Iron deficiency anemia among hospitalized children with microcytic anemia hospitalized in national children's hospital in Vientiane, Lao PDR","volume":"29","author":"Souvanlasy","year":"2019","journal-title":"J\u00a0Hematol Transfus Med"},{"key":"10.1016\/j.lanwpc.2024.101144_bib20","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","article-title":"Ways to fit a PK model with some data below the quantification limit","volume":"28","author":"Beal","year":"2001","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.lanwpc.2024.101144_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10928-011-9201-9","article-title":"Impact of low percentage of data below the quantification limit on parameter estimates of pharmacokinetic models","volume":"38","author":"Xu","year":"2011","journal-title":"J\u00a0Pharmacokinet Pharmacodyn"},{"key":"10.1016\/j.lanwpc.2024.101144_bib22","series-title":"The selection and use of essential medicines 2023: executive summary of the report of the 24th WHO expert committee on the selection and use of essential Medicines, 24 \u2013 28 april 2023","article-title":"World health organization model list of essential Medicines \u2013 23rd list, 2023","author":"Web","year":"2023"},{"key":"10.1016\/j.lanwpc.2024.101144_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007111","article-title":"Neglected tropical diseases in children: an assessment of gaps in research prioritization","volume":"13","author":"Rees","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lanwpc.2024.101144_bib24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1136\/archdischild-2017-314505","article-title":"Question 1: is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg?","volume":"103","author":"Wilkins","year":"2018","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.lanwpc.2024.101144_bib25","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1440-1754.2002.00015.x","article-title":"Ivermectin is better than benzyl benzoate for childhood scabies in developing countries","volume":"38","author":"Brooks","year":"2002","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.lanwpc.2024.101144_bib26","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/bcp.13840","article-title":"Population pharmacokinetics of oral ivermectin in venous plasma and dried blood spots in healthy volunteers","volume":"85","author":"Duthaler","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.lanwpc.2024.101144_bib27","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/1346-8138.13321","article-title":"Effect of high-fat meal intake on the pharmacokinetic profile of ivermectin in Japanese patients with scabies","volume":"43","author":"Miyajima","year":"2016","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.lanwpc.2024.101144_bib28","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S1473-3099(18)30790-4","article-title":"Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial","volume":"19","author":"Romani","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.lanwpc.2024.101144_bib29","first-page":"1690","article-title":"Mass drug administration for scabies control","volume":"374","author":"Steer","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.lanwpc.2024.101144_bib30","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/cid\/ciz444","article-title":"Prevalence of scabies and impetigo 3 years after mass drug administration with ivermectin and azithromycin","volume":"70","author":"Marks","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanwpc.2024.101144_bib31","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0190-9622(00)90131-2","article-title":"A\u00a0comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies","volume":"42","author":"Usha","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.lanwpc.2024.101144_bib32","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2471\/BLT.08.052308","article-title":"Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial","volume":"87","author":"Ly","year":"2009","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.lanwpc.2024.101144_bib33","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4269\/ajtmh.2007.76.392","article-title":"Comparison of ivermectin and benzyl benzoate lotion for scabies in Nigerian patients","volume":"76","author":"Sule","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.lanwpc.2024.101144_bib34","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijpddr.2023.02.004","article-title":"Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife","volume":"21","author":"Takano","year":"2023","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.lanwpc.2024.101144_bib35","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1001\/archderm.138.12.1618","article-title":"Rapid and preferential sebum secretion of ivermectin: a new factor that may determine drug responsiveness in patients with scabies","volume":"138","author":"Haas","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lanwpc.2024.101144_bib36","doi-asserted-by":"crossref","first-page":"e00381","DOI":"10.1128\/AAC.00381-17","article-title":"In\u00a0vitro efficacy of moxidectin versus ivermectin against sarcoptes scabiei","volume":"61","author":"Mounsey","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanwpc.2024.101144_bib37","doi-asserted-by":"crossref","first-page":"e02334","DOI":"10.1128\/AAC.02334-17","article-title":"Efficacy and pharmacokinetics evaluation of a single oral dose of afoxolaner against sarcoptes scabiei in the porcine scabies model for human infestation","volume":"62","author":"Bernigaud","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.lanwpc.2024.101144_bib38","article-title":"Acute visual disturbances and ataxia secondary to attempted COVID-19 prophylaxis with ivermectin in a nine-year-old","volume":"15","author":"Bhardwaj","year":"2023","journal-title":"Cureus"}],"container-title":["The Lancet Regional Health - Western Pacific"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266660652400138X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266660652400138X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T20:58:36Z","timestamp":1728334716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266660652400138X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":36,"alternative-id":["S266660652400138X"],"URL":"https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101144","relation":{},"ISSN":["2666-6065"],"issn-type":[{"value":"2666-6065","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivermectin therapy for young children with scabies infection: a\u00a0multicentre phase 2 non-randomized trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Western Pacific","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanwpc.2024.101144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101144"}}